NCT04540081 2023-12-27
CLOVER
University of California, Davis
Phase NA Completed
Clinical Trials
9 trialsNCT03702231 2023-08-04
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01798056 2021-05-13
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy
GlaxoSmithKline
Phase 3 Completed
NCT03789955 2019-11-19
The Superiority of Contralateral Oblique View for Mid-thoracic Epidural Assess
Asan Medical Center
Phase NA Completed
NCT01254630 2019-09-30
V212-011
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT02902822 2019-05-17
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Centro Studi Gised
Phase NA Completed
NCT01460719 2019-03-11
V212-013
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT01767467 2018-06-06
Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
GlaxoSmithKline
Phase 3 Completed
NCT02444936 2018-04-06
ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors
Louis Stokes VA Medical Center
Phase 4 Unknown